Next Article in Journal
Adenosine 2A Receptor Activation Amplifies Ibrutinib Antiplatelet Effect; Implications in Chronic Lymphocytic Leukemia
Next Article in Special Issue
Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials
Previous Article in Journal
The microRNA Lifecycle in Health and Cancer
 
 
Article
Peer-Review Record

Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma

Cancers 2022, 14(23), 5749; https://doi.org/10.3390/cancers14235749
by Franciscus A. Diepstraten 1, Jan Wiersma 2, Reineke A. Schoot 1, Rutger R. G. Knops 1, Charlotte L. Zuur 3,4, Annelot J. M. Meijer 1, Raquel Dávila Fajardo 1,5, Bradley R. Pieters 2,6, Brian V. Balgobind 2,6, Henrike Westerveld 2,6, Nicole Freling 7, Harm van Tinteren 8, Ludwig E. Smeele 1,3,9, Arjan Bel 2, Marry M. van den Heuvel-Eibrink 1, Robert J. Stokroos 10,11, Johannes H. M. Merks 1, Alexander E. Hoetink 10,11 and Marinka L. F. Hol 1,9,10,*
Reviewer 1:
Reviewer 2:
Reviewer 3:
Cancers 2022, 14(23), 5749; https://doi.org/10.3390/cancers14235749
Submission received: 14 October 2022 / Revised: 16 November 2022 / Accepted: 16 November 2022 / Published: 23 November 2022
(This article belongs to the Special Issue Rhabdomyosarcoma: Still Unresolved Questions but New Perspectives)

Round 1

Reviewer 1 Report

this report is important and certainly of interest to the community of oncologists who treat children with radiation to the CNS

the report is limited by the sample size ( 49) It is also limited by the variability in time of follow up 

 

none the less , few institutions will have access to a larger sample 

Author Response

We would like to thank the reviewer for his/ her comments.

Please see the attachment for the point-by-point response to the reviewer's comments.

 

Author Response File: Author Response.docx

Reviewer 2 Report

 

Dear Editor,

I reviewed the article entitled “Hearing loss in survivors of head and neck rhabdomyosarcoma” by Diepstraten et al. discussing the long-term effect on hearing performance of treatments for head and neck tumors.

Despite the limits of the study, well stated by the authors, the paper has the merit to address a peculiar topic, in a systematic way, adding something to the current literature.

So, I consider this article suitable for publication in Cancers.

Author Response

We would like to thank the reviewer for his/ her positive feedback. 

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 3 Report

The study investigated an interesting topic on the effect of radiotherapy of HNRMS on hearing. Although the study is worthy, it is already well known that RT induces hearing loss. The results are not clearly presented and somewhat vague. The manuscript also needs English editing.

 

- The title is vague. It should indicate what did the authors investigate for the hearing loss in HNRMS. Pattern of hearing loss ? incidence ? the cause of hearing loss ?

- What is the cause of hearing loss in these patients ? Is it radiotherapy or combination with other chemotherapeutic agents ? It should be clearly stated what caused the hearing loss in survivors of HNRMS.

- The first paragraph in the Results section has no subheading.

- There is much limitation to draw a conclusion in this study. Every patients received different treatment. How about other causes of hearing loss such as chemotherapy agents ? Preop hearing is not checked. Were the children checked for tympanic membrane ? Multifactorial analysis is also needed for other causes that is related with hearing loss. The authors should make up these limitations. The conclusion that it is important to purse audiological monitoring is already well known

-  Whole manuscript needs English editing. Please consider sourcing out the manuscript to a native English speaker.

Author Response

We would like to thank the reviewer for his/ her comments.

Please see the attachment for a point-by-point response to the reviewers comments.

Author Response File: Author Response.docx

Round 2

Reviewer 3 Report

The authors answered all the questions successfully. Well done by the authors. I recommend the authors to add the content of their response to question no.4 in the manuscript.

Author Response

We thank the reviewer for his/her valuable recommendation.

Please see the attachement for our point-by-point response. 

Author Response File: Author Response.docx

Back to TopTop